rs372174278
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM1PM2PP3_ModeratePP5
The NM_032620.4(GTPBP3):āc.964G>Cā(p.Ala322Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000916 in 1,605,234 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_032620.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GTPBP3 | NM_032620.4 | c.964G>C | p.Ala322Pro | missense_variant | 7/9 | ENST00000324894.13 | NP_116009.2 | |
GTPBP3 | NM_133644.4 | c.1060G>C | p.Ala354Pro | missense_variant | 6/8 | NP_598399.2 | ||
GTPBP3 | NM_001195422.1 | c.1030G>C | p.Ala344Pro | missense_variant | 7/9 | NP_001182351.1 | ||
GTPBP3 | NM_001128855.3 | c.964G>C | p.Ala322Pro | missense_variant | 7/9 | NP_001122327.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152186Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000117 AC: 27AN: 231342Hom.: 0 AF XY: 0.000173 AC XY: 22AN XY: 126802
GnomAD4 exome AF: 0.0000915 AC: 133AN: 1453048Hom.: 0 Cov.: 36 AF XY: 0.000101 AC XY: 73AN XY: 722922
GnomAD4 genome AF: 0.0000920 AC: 14AN: 152186Hom.: 0 Cov.: 33 AF XY: 0.0000672 AC XY: 5AN XY: 74352
ClinVar
Submissions by phenotype
Combined oxidative phosphorylation defect type 23 Pathogenic:1Uncertain:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Dec 04, 2014 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Centre for Mendelian Genomics, University Medical Centre Ljubljana | Dec 12, 2019 | This variant was classified as: Uncertain significance. The available evidence on this variant's pathogenicity is insufficient or conflicting. The following ACMG criteria were applied in classifying this variant: PP3,PP5,BP6. - |
not provided Pathogenic:1Uncertain:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jun 10, 2022 | Published functional studies demonstrate a damaging effect (reduction of GTPase activity and impaired tRNA modification) (Peng et al., 2021); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Also known as A322P; This variant is associated with the following publications: (PMID: 26832457, 34426522, 33619562, 25434004) - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 22, 2022 | This sequence change replaces alanine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 354 of the GTPBP3 protein (p.Ala354Pro). This variant is present in population databases (rs372174278, gnomAD 0.02%). This missense change has been observed in individual(s) with clinical features of combined oxidative phosphorylation deficiency (PMID: 25434004). This variant is also known as p.Ala322Pro. ClinVar contains an entry for this variant (Variation ID: 180617). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). Experimental studies have shown that this missense change affects GTPBP3 function (PMID: 33619562). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at